Lv01
0 积分 2025-12-18 加入
Probe-General NIR-II In Vivo Lock-in Fluorescence Imaging with Superior Contrast
18分钟前
求助中
Plasmon-Enhanced Interfacial Charge Engineering in Au–Sr Assisted CdS–TiO₂ Heterostructures for Efficient Hydrogen Evolution†
1小时前
求助中
Tuning the Local Environment of Atomic Pt Shells of Pt3Fe@Pt Nanoparticles Enables Energy-Saving Hydrogen Production
1个月前
已完结
Engineered macrophage-assisted atorvastatin nanotherapy for reversing foam cell formation in atherosclerosis
5个月前
已完结
Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma
6个月前
已关闭
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study
6个月前
已完结
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
6个月前
已完结
A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas
6个月前
已完结
皖公网安备34019202002308
